Gene Symbol | Gene ID | Gene Info |
---|---|---|
Six6
|
ENSMUSG00000021099.5 | sine oculis-related homeobox 6 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_72939753_72939904 | Six6 | 64 | 0.747370 | -0.42 | 1.6e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_81642873_81643027 | 34.09 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
9796 |
0.18 |
chr8_120486990_120488549 | 24.45 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr5_134913846_134914156 | 23.43 |
Cldn13 |
claudin 13 |
1525 |
0.2 |
chr8_13122974_13123380 | 22.96 |
Cul4a |
cullin 4A |
348 |
0.77 |
chr7_132778184_132778361 | 22.00 |
Fam53b |
family with sequence similarity 53, member B |
1356 |
0.45 |
chr14_14351950_14353283 | 20.53 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr19_24535123_24535505 | 20.36 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
20475 |
0.18 |
chr10_86352578_86352854 | 20.29 |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
49862 |
0.12 |
chr11_95320033_95320337 | 20.18 |
Gm11520 |
predicted gene 11520 |
9756 |
0.12 |
chr11_95800592_95800866 | 20.01 |
Phospho1 |
phosphatase, orphan 1 |
23770 |
0.1 |
chr4_33467249_33467421 | 19.79 |
Gm11935 |
predicted gene 11935 |
14446 |
0.21 |
chr16_93196994_93197290 | 19.78 |
Gm28003 |
predicted gene, 28003 |
124387 |
0.05 |
chr4_119028467_119028820 | 19.62 |
Gm12862 |
predicted gene 12862 |
28158 |
0.08 |
chr8_94965216_94965406 | 19.61 |
Gm10286 |
predicted gene 10286 |
4443 |
0.14 |
chr11_44508913_44509245 | 19.43 |
Rnf145 |
ring finger protein 145 |
9885 |
0.16 |
chr2_105769867_105770156 | 19.02 |
Elp4 |
elongator acetyltransferase complex subunit 4 |
44311 |
0.13 |
chr6_120605559_120605721 | 18.38 |
Gm44124 |
predicted gene, 44124 |
25464 |
0.13 |
chr3_152549002_152549525 | 18.09 |
Ak5 |
adenylate kinase 5 |
22511 |
0.2 |
chr1_135941196_135941555 | 17.85 |
Igfn1 |
immunoglobulin-like and fibronectin type III domain containing 1 |
21765 |
0.12 |
chr7_123353967_123354476 | 17.29 |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
15563 |
0.17 |
chr17_84778620_84778830 | 16.82 |
Lrpprc |
leucine-rich PPR-motif containing |
1182 |
0.44 |
chr3_89132835_89133000 | 16.60 |
Pklr |
pyruvate kinase liver and red blood cell |
3225 |
0.09 |
chr13_112073588_112073874 | 16.39 |
Gm31104 |
predicted gene, 31104 |
64385 |
0.09 |
chr7_135817975_135818155 | 16.32 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
35617 |
0.13 |
chr18_56977792_56978080 | 16.28 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
2568 |
0.32 |
chrX_162284682_162284939 | 16.27 |
Gm27490 |
predicted gene, 27490 |
47711 |
0.15 |
chr7_133702854_133703005 | 16.11 |
Uros |
uroporphyrinogen III synthase |
313 |
0.83 |
chr12_17538465_17538623 | 16.05 |
Odc1 |
ornithine decarboxylase, structural 1 |
6250 |
0.15 |
chr11_78072843_78073236 | 15.94 |
Mir144 |
microRNA 144 |
34 |
0.49 |
chr1_185731040_185731213 | 15.35 |
Gm38093 |
predicted gene, 38093 |
13677 |
0.27 |
chr10_43630601_43630939 | 15.32 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
7023 |
0.14 |
chr15_78413114_78413438 | 15.31 |
Mpst |
mercaptopyruvate sulfurtransferase |
3294 |
0.12 |
chr10_54038165_54038485 | 15.24 |
Gm47917 |
predicted gene, 47917 |
25486 |
0.18 |
chr6_67187272_67187443 | 15.17 |
Gm8566 |
predicted pseudogene 8566 |
18262 |
0.13 |
chr4_43598616_43598767 | 15.02 |
Gm12472 |
predicted gene 12472 |
10619 |
0.07 |
chr2_79270002_79270159 | 14.71 |
Itga4 |
integrin alpha 4 |
14133 |
0.22 |
chr6_35254101_35254395 | 14.67 |
1810058I24Rik |
RIKEN cDNA 1810058I24 gene |
1516 |
0.33 |
chr14_47527928_47528092 | 14.56 |
Fbxo34 |
F-box protein 34 |
1931 |
0.23 |
chr4_87805858_87806167 | 14.35 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
282 |
0.95 |
chr6_138424907_138425582 | 14.16 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr6_86639472_86639652 | 14.08 |
Asprv1 |
aspartic peptidase, retroviral-like 1 |
11398 |
0.11 |
chr2_91045957_91046231 | 14.08 |
Rapsn |
receptor-associated protein of the synapse |
3309 |
0.13 |
chr13_118629682_118629962 | 14.05 |
Gm10732 |
predicted gene 10732 |
28921 |
0.13 |
chr2_84811935_84812131 | 14.04 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
5804 |
0.11 |
chr17_78328309_78328607 | 13.89 |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
22431 |
0.16 |
chr6_31658559_31658740 | 13.86 |
Gm43154 |
predicted gene 43154 |
5243 |
0.2 |
chr12_32104084_32104385 | 13.85 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
19468 |
0.16 |
chr2_127374849_127375033 | 13.82 |
Adra2b |
adrenergic receptor, alpha 2b |
11655 |
0.14 |
chr11_86663309_86663497 | 13.80 |
Vmp1 |
vacuole membrane protein 1 |
170 |
0.94 |
chr2_25115482_25115813 | 13.78 |
AL732309.1 |
exonuclease 3'-5' domain containing 3 (EXD3) pseudogene |
634 |
0.5 |
chr16_76319178_76320114 | 13.58 |
Nrip1 |
nuclear receptor interacting protein 1 |
4012 |
0.29 |
chr8_80501322_80501634 | 13.52 |
Gypa |
glycophorin A |
7697 |
0.23 |
chr8_84900828_84901106 | 13.47 |
Klf1 |
Kruppel-like factor 1 (erythroid) |
961 |
0.28 |
chr13_112871991_112872154 | 13.46 |
Mtrex |
Mtr4 exosome RNA helicase |
947 |
0.5 |
chr9_115166107_115166297 | 13.38 |
Gm4665 |
predicted gene 4665 |
19856 |
0.15 |
chr3_37274850_37275035 | 13.33 |
Gm24169 |
predicted gene, 24169 |
18049 |
0.09 |
chr11_104661106_104661444 | 13.31 |
Gm11662 |
predicted gene 11662 |
19380 |
0.14 |
chr18_34519493_34519793 | 13.31 |
n-R5s24 |
nuclear encoded rRNA 5S 24 |
9906 |
0.14 |
chr7_97210418_97210570 | 13.27 |
Usp35 |
ubiquitin specific peptidase 35 |
104531 |
0.06 |
chr3_100436826_100437140 | 13.23 |
Gm43121 |
predicted gene 43121 |
851 |
0.54 |
chr19_5967617_5967939 | 13.20 |
Pola2 |
polymerase (DNA directed), alpha 2 |
3576 |
0.1 |
chr15_86105433_86105656 | 13.19 |
Gm15722 |
predicted gene 15722 |
15484 |
0.17 |
chr18_62174603_62175149 | 13.13 |
Adrb2 |
adrenergic receptor, beta 2 |
5083 |
0.21 |
chr12_3285550_3285711 | 13.03 |
Rab10 |
RAB10, member RAS oncogene family |
24339 |
0.14 |
chr19_55284094_55284395 | 12.96 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
90 |
0.97 |
chr6_117888406_117888588 | 12.93 |
Gm29509 |
predicted gene 29509 |
10704 |
0.11 |
chr15_66827139_66827411 | 12.90 |
Sla |
src-like adaptor |
4371 |
0.23 |
chr9_32101597_32101753 | 12.90 |
Arhgap32 |
Rho GTPase activating protein 32 |
14461 |
0.15 |
chr5_103745745_103745929 | 12.77 |
Aff1 |
AF4/FMR2 family, member 1 |
8325 |
0.21 |
chr1_91278883_91279043 | 12.74 |
Ube2f |
ubiquitin-conjugating enzyme E2F (putative) |
2852 |
0.18 |
chr11_86664070_86664249 | 12.71 |
Vmp1 |
vacuole membrane protein 1 |
586 |
0.71 |
chr15_83425276_83425627 | 12.71 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
1661 |
0.32 |
chr1_181257261_181257857 | 12.68 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
15239 |
0.14 |
chr7_109817964_109818290 | 12.63 |
Scube2 |
signal peptide, CUB domain, EGF-like 2 |
9896 |
0.14 |
chr15_86104740_86104959 | 12.52 |
Gm15722 |
predicted gene 15722 |
14789 |
0.17 |
chr6_125565069_125565345 | 12.47 |
Vwf |
Von Willebrand factor |
1044 |
0.56 |
chr10_68155376_68155703 | 12.46 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
18913 |
0.24 |
chrX_160905132_160905470 | 12.44 |
Gja6 |
gap junction protein, alpha 6 |
1751 |
0.42 |
chr9_16214764_16215041 | 12.40 |
Fat3 |
FAT atypical cadherin 3 |
163329 |
0.04 |
chr7_103865311_103865713 | 12.30 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12296 |
0.06 |
chr7_135813684_135813871 | 12.23 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
39905 |
0.12 |
chr19_53824841_53825326 | 12.15 |
Gm16299 |
predicted gene 16299 |
45 |
0.97 |
chr19_59906187_59906390 | 12.07 |
Gm17203 |
predicted gene 17203 |
5226 |
0.23 |
chr11_74575887_74576243 | 12.05 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
14059 |
0.18 |
chr5_123196731_123197228 | 12.02 |
Gm43409 |
predicted gene 43409 |
5391 |
0.11 |
chr4_41331115_41331433 | 12.00 |
Gm26084 |
predicted gene, 26084 |
14677 |
0.1 |
chr11_120900722_120900885 | 11.91 |
Ccdc57 |
coiled-coil domain containing 57 |
14892 |
0.11 |
chr12_83375440_83375754 | 11.90 |
Dpf3 |
D4, zinc and double PHD fingers, family 3 |
24702 |
0.22 |
chr5_123094799_123094959 | 11.90 |
Tmem120b |
transmembrane protein 120B |
5022 |
0.1 |
chr2_74847070_74847233 | 11.89 |
Gm14425 |
predicted gene 14425 |
8555 |
0.13 |
chr16_60265186_60265473 | 11.80 |
Gm24755 |
predicted gene, 24755 |
103834 |
0.08 |
chr2_131243115_131243266 | 11.77 |
Mavs |
mitochondrial antiviral signaling protein |
1256 |
0.31 |
chr17_83651316_83651614 | 11.70 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
19570 |
0.22 |
chr5_139805983_139806169 | 11.69 |
Tmem184a |
transmembrane protein 184a |
1904 |
0.22 |
chr7_144492958_144493263 | 11.64 |
Ppfia1 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 |
3773 |
0.2 |
chr14_14354416_14355184 | 11.56 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr3_121291927_121292619 | 11.55 |
Alg14 |
asparagine-linked glycosylation 14 |
383 |
0.82 |
chr19_9989798_9990534 | 11.54 |
Best1 |
bestrophin 1 |
2749 |
0.15 |
chr7_51851013_51851172 | 11.47 |
Gm45001 |
predicted gene 45001 |
788 |
0.56 |
chr2_118963135_118963341 | 11.46 |
Gm14089 |
predicted gene 14089 |
33830 |
0.1 |
chr10_115817172_115817352 | 11.44 |
Tspan8 |
tetraspanin 8 |
9 |
0.99 |
chr9_116866223_116866394 | 11.37 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
43489 |
0.21 |
chr18_62180293_62180673 | 11.37 |
Gm9949 |
predicted gene 9949 |
357 |
0.62 |
chr13_99017926_99018177 | 11.27 |
A930014D07Rik |
RIKEN cDNA A930014D07 gene |
10952 |
0.12 |
chr13_13930048_13930314 | 11.26 |
Gm7046 |
predicted gene 7046 |
19773 |
0.11 |
chr12_32050211_32050499 | 11.22 |
Prkar2b |
protein kinase, cAMP dependent regulatory, type II beta |
10234 |
0.2 |
chr2_151038017_151038184 | 11.20 |
Nanp |
N-acetylneuraminic acid phosphatase |
1262 |
0.26 |
chr16_36890395_36890556 | 11.19 |
Gm49600 |
predicted gene, 49600 |
3919 |
0.11 |
chr1_184645271_184645605 | 11.04 |
Gm37800 |
predicted gene, 37800 |
15965 |
0.15 |
chr13_105139845_105140060 | 11.01 |
Nt5el |
5' nucleotidase, ecto-like |
57830 |
0.13 |
chr16_32520471_32520655 | 10.94 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
20952 |
0.12 |
chrX_71526037_71526198 | 10.94 |
Gm23945 |
predicted gene, 23945 |
5259 |
0.19 |
chr6_113373617_113373789 | 10.93 |
Tada3 |
transcriptional adaptor 3 |
2561 |
0.11 |
chr11_96925843_96926029 | 10.93 |
Prr15l |
proline rich 15-like |
2168 |
0.15 |
chr2_61514448_61514599 | 10.91 |
Gm22338 |
predicted gene, 22338 |
21757 |
0.24 |
chr7_4739300_4740219 | 10.86 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr8_68259367_68259714 | 10.83 |
Sh2d4a |
SH2 domain containing 4A |
17027 |
0.19 |
chr8_14890288_14890615 | 10.81 |
Cln8 |
CLN8 transmembrane ER and ERGIC protein |
1092 |
0.51 |
chr11_57657809_57657989 | 10.78 |
4933426K07Rik |
RIKEN cDNA 4933426K07 gene |
73 |
0.97 |
chr4_145200648_145200824 | 10.76 |
Vps13d |
vacuolar protein sorting 13D |
5731 |
0.24 |
chr14_70713082_70713272 | 10.71 |
Xpo7 |
exportin 7 |
5142 |
0.18 |
chr1_58962444_58962764 | 10.70 |
Trak2 |
trafficking protein, kinesin binding 2 |
10825 |
0.14 |
chr1_156995537_156995838 | 10.68 |
Gm10531 |
predicted gene 10531 |
47860 |
0.1 |
chr1_73046888_73047083 | 10.67 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
22416 |
0.2 |
chr17_83684505_83684810 | 10.64 |
Mta3 |
metastasis associated 3 |
21506 |
0.21 |
chr5_130033922_130034092 | 10.62 |
Crcp |
calcitonin gene-related peptide-receptor component protein |
4664 |
0.14 |
chr4_53139613_53139963 | 10.58 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
20107 |
0.2 |
chr5_27709268_27709429 | 10.53 |
Paxip1 |
PAX interacting (with transcription-activation domain) protein 1 |
41947 |
0.16 |
chr19_55938421_55938984 | 10.51 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40393 |
0.17 |
chr2_165884402_165885933 | 10.50 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr4_131888688_131888840 | 10.49 |
Srsf4 |
serine and arginine-rich splicing factor 4 |
3556 |
0.13 |
chr4_111503479_111503635 | 10.49 |
Agbl4 |
ATP/GTP binding protein-like 4 |
63138 |
0.12 |
chr4_45402888_45403200 | 10.46 |
Slc25a51 |
solute carrier family 25, member 51 |
1822 |
0.27 |
chr6_38929161_38929494 | 10.46 |
Tbxas1 |
thromboxane A synthase 1, platelet |
10303 |
0.2 |
chr12_24890162_24890450 | 10.43 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
58675 |
0.09 |
chr7_119280023_119280181 | 10.40 |
Gm4083 |
predicted gene 4083 |
21605 |
0.18 |
chr6_87809607_87810170 | 10.29 |
Rab43 |
RAB43, member RAS oncogene family |
131 |
0.89 |
chr6_125095392_125097556 | 10.28 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr11_87758298_87758558 | 10.24 |
Mir142b |
microRNA 142b |
1473 |
0.18 |
chr7_103913044_103913396 | 10.17 |
Olfr65 |
olfactory receptor 65 |
6878 |
0.06 |
chr12_79611728_79611895 | 10.15 |
Rad51b |
RAD51 paralog B |
284458 |
0.01 |
chr4_49451596_49451772 | 10.13 |
Acnat1 |
acyl-coenzyme A amino acid N-acyltransferase 1 |
547 |
0.69 |
chr11_3170338_3170795 | 10.09 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
138 |
0.93 |
chr15_78413766_78414029 | 10.04 |
Mpst |
mercaptopyruvate sulfurtransferase |
3915 |
0.11 |
chr3_138612584_138612857 | 9.96 |
Gm6057 |
predicted gene 6057 |
7736 |
0.14 |
chr17_24354013_24354319 | 9.93 |
Abca3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
2064 |
0.17 |
chr5_146316844_146317241 | 9.89 |
Cdk8 |
cyclin-dependent kinase 8 |
20677 |
0.16 |
chr8_117196597_117196816 | 9.81 |
Gan |
giant axonal neuropathy |
38569 |
0.15 |
chr13_112745764_112745944 | 9.79 |
Slc38a9 |
solute carrier family 38, member 9 |
10244 |
0.15 |
chr6_108207290_108207451 | 9.79 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
5726 |
0.24 |
chr7_19224973_19225310 | 9.79 |
Opa3 |
optic atrophy 3 |
3193 |
0.1 |
chr7_17059591_17061170 | 9.78 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1846 |
0.19 |
chr17_79969002_79969199 | 9.70 |
Gm41625 |
predicted gene, 41625 |
12562 |
0.16 |
chr1_173333973_173334136 | 9.70 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
304 |
0.86 |
chr5_137786077_137787112 | 9.68 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr9_52103873_52104213 | 9.67 |
Gm27686 |
predicted gene, 27686 |
264 |
0.91 |
chr6_121052051_121052202 | 9.66 |
Gm4651 |
predicted gene 4651 |
12338 |
0.16 |
chr10_118064868_118065238 | 9.65 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
47464 |
0.11 |
chr6_5292506_5292674 | 9.61 |
Pon2 |
paraoxonase 2 |
3522 |
0.22 |
chr12_32110960_32111262 | 9.59 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
12591 |
0.18 |
chr8_122682815_122683151 | 9.59 |
Gm15899 |
predicted gene 15899 |
856 |
0.43 |
chr5_96921082_96921373 | 9.59 |
Gm8013 |
predicted gene 8013 |
45 |
0.93 |
chr12_84358342_84358507 | 9.59 |
Coq6 |
coenzyme Q6 monooxygenase |
3233 |
0.14 |
chr19_38820529_38820766 | 9.56 |
Noc3l |
NOC3 like DNA replication regulator |
1410 |
0.43 |
chr2_33842970_33843153 | 9.52 |
Nron |
non-protein coding RNA, repressor of NFAT |
37202 |
0.15 |
chr2_120697877_120698039 | 9.51 |
Stard9 |
START domain containing 9 |
3383 |
0.22 |
chr8_117074324_117074607 | 9.48 |
Pkd1l2 |
polycystic kidney disease 1 like 2 |
7984 |
0.16 |
chr13_75729945_75730132 | 9.47 |
Gm48302 |
predicted gene, 48302 |
2759 |
0.19 |
chr7_24371478_24371804 | 9.46 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1303 |
0.24 |
chr17_70850487_70852089 | 9.41 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr13_3861425_3861583 | 9.37 |
Calm5 |
calmodulin 5 |
7236 |
0.12 |
chr5_102045029_102045180 | 9.36 |
Gm43787 |
predicted gene 43787 |
12965 |
0.18 |
chr16_8675894_8676084 | 9.35 |
Carhsp1 |
calcium regulated heat stable protein 1 |
3834 |
0.14 |
chr5_4004856_4005069 | 9.34 |
Wdr46-ps |
Wdr46 retrotransposed pseudogene |
15956 |
0.17 |
chr8_107402774_107403333 | 9.33 |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
153 |
0.94 |
chr10_80571146_80571871 | 9.33 |
Klf16 |
Kruppel-like factor 16 |
5813 |
0.08 |
chr18_21288530_21288812 | 9.33 |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
11452 |
0.18 |
chr5_142920749_142921092 | 9.32 |
Actb |
actin, beta |
14166 |
0.14 |
chr4_87806707_87807032 | 9.32 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
546 |
0.86 |
chr11_84823504_84823973 | 9.21 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
4223 |
0.13 |
chr17_61960089_61960430 | 9.20 |
Gm49859 |
predicted gene, 49859 |
87884 |
0.1 |
chr2_170158021_170158172 | 9.20 |
Zfp217 |
zinc finger protein 217 |
9993 |
0.28 |
chr13_6549824_6550015 | 9.15 |
Pitrm1 |
pitrilysin metallepetidase 1 |
1684 |
0.38 |
chr11_78833258_78833433 | 9.15 |
Lyrm9 |
LYR motif containing 9 |
6716 |
0.17 |
chr1_156745548_156745740 | 9.12 |
Fam20b |
family with sequence similarity 20, member B |
26558 |
0.14 |
chr19_37442831_37443030 | 9.12 |
Hhex |
hematopoietically expressed homeobox |
6191 |
0.13 |
chr13_96966536_96966697 | 9.12 |
Gm48597 |
predicted gene, 48597 |
15702 |
0.15 |
chr7_103808332_103808505 | 9.09 |
Hbb-bt |
hemoglobin, beta adult t chain |
5578 |
0.07 |
chr12_40027947_40028127 | 9.09 |
Arl4a |
ADP-ribosylation factor-like 4A |
9330 |
0.19 |
chr1_185454557_185455710 | 9.08 |
Slc30a10 |
solute carrier family 30, member 10 |
95 |
0.83 |
chr4_105261004_105261461 | 9.07 |
Plpp3 |
phospholipid phosphatase 3 |
103885 |
0.07 |
chr16_91464461_91465455 | 9.06 |
A930006K02Rik |
RIKEN cDNA A930006K02 gene |
67 |
0.46 |
chr4_119133436_119133597 | 8.99 |
Gm12867 |
predicted gene 12867 |
2515 |
0.14 |
chr10_118581520_118581685 | 8.99 |
Ifngas1 |
Ifng antisense RNA 1 |
25077 |
0.2 |
chr4_109255748_109256041 | 8.91 |
Calr4 |
calreticulin 4 |
11312 |
0.19 |
chr11_5002790_5002941 | 8.90 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
6609 |
0.14 |
chr14_21078062_21078252 | 8.87 |
Adk |
adenosine kinase |
2005 |
0.36 |
chr13_51979366_51979590 | 8.84 |
Gm26651 |
predicted gene, 26651 |
6264 |
0.25 |
chr11_11656542_11656800 | 8.84 |
Ikzf1 |
IKAROS family zinc finger 1 |
28332 |
0.13 |
chr10_128625255_128625548 | 8.83 |
Rps26 |
ribosomal protein S26 |
1023 |
0.27 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.5 | GO:0040031 | snRNA modification(GO:0040031) |
3.5 | 10.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
3.0 | 20.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.6 | 7.9 | GO:0002086 | diaphragm contraction(GO:0002086) |
2.6 | 7.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.4 | 9.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
2.4 | 9.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
2.3 | 6.8 | GO:0070268 | cornification(GO:0070268) |
2.2 | 13.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
2.2 | 13.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.2 | 21.9 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
2.2 | 6.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.2 | 8.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.9 | 5.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 5.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.9 | 5.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.8 | 5.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.8 | 5.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.8 | 5.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.8 | 3.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.8 | 8.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.8 | 7.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.7 | 7.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.7 | 5.2 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.7 | 6.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.6 | 3.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.5 | 4.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.5 | 4.6 | GO:0007525 | somatic muscle development(GO:0007525) |
1.5 | 6.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.5 | 3.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.5 | 4.5 | GO:0008228 | opsonization(GO:0008228) |
1.5 | 6.0 | GO:0018343 | protein farnesylation(GO:0018343) |
1.5 | 5.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.5 | 1.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.5 | 4.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.5 | 4.4 | GO:0050904 | diapedesis(GO:0050904) |
1.4 | 5.6 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.4 | 4.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.4 | 6.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.4 | 4.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.4 | 4.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.3 | 6.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.3 | 1.3 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.3 | 5.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.3 | 1.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.3 | 5.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.3 | 3.9 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.3 | 6.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.3 | 6.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.3 | 1.3 | GO:0070671 | response to interleukin-12(GO:0070671) |
1.3 | 8.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.3 | 8.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.2 | 3.7 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.2 | 3.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.2 | 7.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.2 | 3.7 | GO:0042117 | monocyte activation(GO:0042117) |
1.2 | 2.4 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.2 | 29.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.2 | 4.8 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.2 | 1.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.2 | 4.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.2 | 5.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.2 | 1.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.2 | 3.5 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.2 | 5.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.2 | 8.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
1.2 | 5.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.1 | 5.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.1 | 4.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
1.1 | 3.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.1 | 3.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.1 | 2.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.1 | 11.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.1 | 3.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.1 | 8.7 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
1.1 | 2.2 | GO:0070384 | Harderian gland development(GO:0070384) |
1.1 | 1.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
1.1 | 4.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.1 | 3.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.1 | 5.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.1 | 4.3 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
1.1 | 8.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.1 | 3.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.0 | 3.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.0 | 2.1 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.0 | 3.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.0 | 3.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.0 | 8.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.0 | 6.0 | GO:0015671 | oxygen transport(GO:0015671) |
1.0 | 6.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.0 | 4.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.0 | 1.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.9 | 2.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 1.9 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.9 | 3.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.9 | 9.2 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.9 | 7.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.9 | 3.7 | GO:2000562 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.9 | 5.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.9 | 4.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.9 | 1.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.9 | 3.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.9 | 0.9 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.9 | 5.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.9 | 2.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.9 | 7.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.9 | 3.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.9 | 3.5 | GO:0031508 | chromatin remodeling at centromere(GO:0031055) pericentric heterochromatin assembly(GO:0031508) |
0.9 | 3.5 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.9 | 1.7 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.9 | 2.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.9 | 2.6 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.9 | 4.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.9 | 10.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.8 | 5.9 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.8 | 2.5 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.8 | 2.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.8 | 3.4 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.8 | 3.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.8 | 4.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 2.5 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.8 | 1.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.8 | 7.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 2.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.8 | 4.9 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.8 | 0.8 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.8 | 0.8 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.8 | 3.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.8 | 2.3 | GO:0032264 | IMP salvage(GO:0032264) |
0.8 | 3.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 2.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.8 | 5.4 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.8 | 2.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.8 | 2.3 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.8 | 1.5 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.8 | 2.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.8 | 1.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.8 | 2.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 2.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.7 | 3.7 | GO:1901563 | response to camptothecin(GO:1901563) |
0.7 | 2.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.7 | 3.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 3.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.7 | 2.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.7 | 2.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.7 | 2.2 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.7 | 1.5 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 0.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.7 | 2.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.7 | 2.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.7 | 2.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.7 | 2.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 2.1 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.7 | 1.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.7 | 3.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.7 | 4.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.7 | 2.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 2.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 1.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.7 | 3.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.7 | 3.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 2.8 | GO:0010288 | response to lead ion(GO:0010288) |
0.7 | 7.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.7 | 6.8 | GO:0051198 | negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.7 | 6.8 | GO:0015816 | glycine transport(GO:0015816) |
0.7 | 6.8 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.7 | 4.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 1.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.7 | 0.7 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.7 | 4.0 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.7 | 2.0 | GO:0061010 | gall bladder development(GO:0061010) |
0.7 | 0.7 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.7 | 0.7 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.7 | 0.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.7 | 6.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.7 | 1.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.6 | 4.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 11.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.6 | 5.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.6 | 7.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.6 | 3.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 2.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.6 | 0.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 4.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.6 | 1.9 | GO:0030242 | pexophagy(GO:0030242) |
0.6 | 1.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.6 | 4.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.6 | 2.5 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.6 | 0.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.6 | 1.9 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.6 | 1.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.6 | 1.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.6 | 4.3 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.6 | 0.6 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.6 | 5.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.6 | 1.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.6 | 0.6 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.6 | 3.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.6 | 3.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.6 | 19.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.6 | 1.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.6 | 1.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.6 | 1.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 1.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 0.6 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.6 | 0.6 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.6 | 4.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.6 | 1.8 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.6 | 3.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.6 | 1.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.6 | 2.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.6 | 1.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 2.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.6 | 1.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.6 | 2.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.6 | 3.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.6 | 4.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 0.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.6 | 1.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.6 | 4.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.6 | 1.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 0.6 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.6 | 1.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.6 | 1.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.6 | 2.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.6 | 2.8 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.6 | 6.8 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.6 | 2.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.6 | 1.7 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 | 2.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.6 | 1.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 1.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.6 | 2.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.6 | 1.7 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.6 | 18.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.6 | 1.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.6 | 2.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.6 | 1.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.5 | 1.6 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.5 | 1.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 2.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.5 | 3.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.5 | 3.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 1.1 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.5 | 7.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.5 | 2.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 1.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.5 | 1.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.5 | 2.7 | GO:0072553 | terminal button organization(GO:0072553) |
0.5 | 1.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 1.6 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.5 | 1.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.5 | 1.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.5 | 2.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 1.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.5 | 2.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 4.7 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.5 | 2.1 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.5 | 1.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.5 | 1.6 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.5 | 1.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.5 | 3.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.5 | 1.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 2.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.5 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 1.5 | GO:1901881 | positive regulation of protein complex disassembly(GO:0043243) positive regulation of protein depolymerization(GO:1901881) |
0.5 | 0.5 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.5 | 2.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.5 | 3.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.5 | 6.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.5 | 1.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 1.0 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.5 | 1.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.5 | 1.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.5 | 1.0 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.5 | 1.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.5 | 6.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 2.9 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.5 | 2.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.5 | 2.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 2.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 2.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.5 | 1.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 3.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.5 | 2.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.5 | 1.9 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.5 | 1.9 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.5 | 1.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 1.4 | GO:0050955 | thermoception(GO:0050955) |
0.5 | 1.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 1.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 4.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 1.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.5 | 4.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.5 | 2.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.5 | 3.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 3.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.5 | 1.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 4.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 1.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 2.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 1.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 0.5 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.5 | 2.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 3.6 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 2.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.5 | 5.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 1.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 1.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 0.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.4 | 1.8 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.4 | 1.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 1.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 1.8 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 1.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 2.6 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.4 | 3.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.4 | 0.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 2.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 3.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 2.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.4 | 1.7 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.4 | 2.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.4 | 1.7 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.4 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 6.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 1.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.4 | 3.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 0.8 | GO:0035799 | ureter maturation(GO:0035799) |
0.4 | 1.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 2.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 1.7 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.4 | 0.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.4 | 0.4 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.4 | 0.4 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.4 | 1.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 1.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 | 2.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 1.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 3.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 2.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 0.8 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 2.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.4 | 2.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 4.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.4 | 11.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 5.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 1.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.4 | 0.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 5.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 2.8 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 3.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 2.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 4.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 0.4 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.4 | 5.5 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.4 | 0.8 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.4 | 0.8 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 1.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 1.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 2.3 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.4 | 1.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 1.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 1.5 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.4 | 0.8 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.4 | 2.3 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 0.4 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 0.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 0.8 | GO:0072718 | response to cisplatin(GO:0072718) |
0.4 | 1.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.4 | 1.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 1.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 0.7 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.4 | 0.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 1.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 1.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.4 | 0.7 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.4 | 2.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 1.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.4 | 2.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 1.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 0.7 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.4 | 0.4 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.4 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 1.1 | GO:0051194 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.4 | 1.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 0.7 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 0.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 6.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.4 | 1.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 4.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 1.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.4 | 6.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.4 | 1.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.4 | 0.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 1.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 1.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 3.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 0.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 2.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 4.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 4.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.3 | 0.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 1.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 2.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.3 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.3 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.3 | 3.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.3 | 1.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 1.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 3.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 6.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.3 | 2.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 2.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 5.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.3 | 0.7 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.3 | 1.0 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 1.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 1.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 2.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 4.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 2.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 3.3 | GO:0006560 | proline metabolic process(GO:0006560) |
0.3 | 1.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 1.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 0.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 5.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.3 | 0.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.3 | 0.3 | GO:1903596 | angiotensin-mediated drinking behavior(GO:0003051) regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.3 | 1.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 1.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 1.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 0.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.3 | 6.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.3 | 1.0 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 7.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 0.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 2.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 1.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.3 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 0.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.3 | 2.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 1.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 0.3 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.3 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 1.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 0.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.3 | 0.6 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 2.8 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.3 | 2.5 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 1.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 1.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.3 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.3 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.3 | 1.2 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.3 | 1.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 0.3 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.3 | 0.6 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.3 | 0.6 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 3.7 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.3 | 0.6 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 1.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 2.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 0.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.3 | 0.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 1.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 6.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.3 | 0.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 3.3 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 1.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.3 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 3.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 0.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 2.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 9.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 0.6 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.3 | 0.9 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.3 | 4.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 1.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 0.9 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 3.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 0.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 1.5 | GO:0042511 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.3 | 4.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.3 | 1.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 18.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 1.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.9 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 0.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 16.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 0.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 1.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.3 | 3.9 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.3 | 0.8 | GO:0072677 | eosinophil migration(GO:0072677) |
0.3 | 0.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.3 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 10.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.3 | 0.6 | GO:0009838 | abscission(GO:0009838) |
0.3 | 3.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 0.3 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.3 | 1.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 0.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 1.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 6.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 1.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 0.8 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.3 | 1.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.5 | GO:0035483 | gastric emptying(GO:0035483) |
0.3 | 0.8 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.3 | 0.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 1.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 4.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 0.8 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 0.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 0.8 | GO:0051029 | rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
0.3 | 1.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.3 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.3 | 1.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.3 | 2.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 0.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 1.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.5 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.3 | 5.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 0.8 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.3 | 0.3 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.3 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 0.8 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 0.3 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.3 | 2.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 1.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 0.3 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 1.0 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.3 | 1.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 0.8 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.3 | 1.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 0.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 1.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 1.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.5 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.3 | 2.3 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.3 | 2.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 1.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 1.0 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.2 | 1.2 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 4.2 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 1.2 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.2 | 1.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 1.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 4.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.2 | 1.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 1.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.2 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.2 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 1.0 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 1.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 4.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 4.9 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 1.7 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 1.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 3.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.7 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 2.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 1.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 1.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.9 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 0.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 3.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 1.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.2 | GO:1904874 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.2 | 9.9 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 2.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 11.9 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 2.5 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 1.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.2 | 1.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 0.9 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 1.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.7 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 0.7 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.9 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 0.2 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.2 | 4.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.2 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.2 | 0.4 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.2 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.4 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.2 | 2.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 2.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 2.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.2 | 0.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 0.9 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 1.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.7 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.3 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.2 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 1.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.9 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.2 | 0.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.2 | GO:2000049 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 1.3 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 1.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 0.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.2 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 0.8 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 0.8 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 1.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 3.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.2 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.2 | 7.3 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 1.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 0.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 1.9 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.2 | 1.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 0.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.8 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 1.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 1.0 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.2 | 1.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 4.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.4 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.2 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 1.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 1.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 2.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 1.8 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 1.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 1.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.4 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.8 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 1.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 1.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.4 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.8 | GO:0006825 | copper ion transport(GO:0006825) |
0.2 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.6 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 1.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 0.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 4.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 1.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 1.5 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 1.1 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.2 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 1.7 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.2 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.2 | 1.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 1.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 1.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.2 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
0.2 | 3.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 3.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.6 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 2.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 5.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 1.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 3.1 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.2 | 1.6 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.9 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.7 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 1.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.2 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 0.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 1.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 1.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 1.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.9 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.4 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.5 | GO:0009155 | dGTP catabolic process(GO:0006203) purine deoxyribonucleotide catabolic process(GO:0009155) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.2 | 1.2 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 0.5 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 0.7 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.3 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 3.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.2 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 2.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 1.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 0.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 1.2 | GO:0009651 | response to salt stress(GO:0009651) |
0.2 | 0.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.2 | GO:1901145 | regulation of kidney size(GO:0035564) regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.2 | 2.0 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.2 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 5.2 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.7 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 0.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 3.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.5 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 1.6 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 2.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 1.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.5 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.2 | 2.1 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.2 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.2 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.2 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.2 | 0.6 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 0.2 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.2 | 0.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 0.8 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 1.3 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.2 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.2 | 0.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.5 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.2 | 0.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.2 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.2 | 2.2 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.2 | 0.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.2 | 0.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 5.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 1.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 0.2 | GO:0009208 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.2 | 0.3 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 0.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 1.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.3 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 1.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.9 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 3.8 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 1.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.7 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 1.6 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.7 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 | 0.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.1 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.1 | 0.3 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 4.0 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.7 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.9 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 1.0 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 12.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 2.8 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.3 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.1 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.4 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.1 | 1.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 1.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 3.6 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.8 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.4 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 2.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.1 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.3 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.1 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.6 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 0.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.9 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 3.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 1.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.4 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.1 | 0.6 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.3 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.1 | GO:0060430 | lung saccule development(GO:0060430) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 2.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.4 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 1.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 5.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 1.9 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.1 | 0.1 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 0.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.2 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.1 | 1.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.5 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.5 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 1.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 2.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.6 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 2.5 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.7 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 1.5 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.2 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.2 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 13.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 2.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 1.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 3.0 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 1.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.2 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.9 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 4.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.8 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 1.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.3 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.1 | 0.8 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.6 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 1.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.5 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.7 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 6.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.1 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 6.1 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.1 | 0.3 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.2 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.1 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.3 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 1.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 2.3 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 1.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 1.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.5 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 1.8 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.3 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.8 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 2.7 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.3 | GO:0032722 | positive regulation of chemokine production(GO:0032722) |
0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.3 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.1 | 1.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.3 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.2 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.7 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.1 | 1.0 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 1.4 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.1 | GO:0034447 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.9 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.2 | GO:1901570 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.2 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.1 | 0.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.1 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 14.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 6.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 1.0 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.1 | 0.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.6 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.2 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.4 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 1.3 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 0.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.4 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.1 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.1 | 0.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.2 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.1 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 0.1 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.1 | 0.1 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.5 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.1 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.1 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.1 | 0.1 | GO:0072526 | NADP catabolic process(GO:0006742) pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.9 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.3 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.3 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:0048793 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) pronephros development(GO:0048793) |
0.1 | 0.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.3 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.1 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.3 | GO:0044246 | regulation of multicellular organismal metabolic process(GO:0044246) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:0045953 | negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 1.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:1903206 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.3 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.0 | 0.0 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.0 | 0.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.5 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.1 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.0 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 1.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 11.3 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.0 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 1.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.4 | GO:0032355 | response to estradiol(GO:0032355) |
0.0 | 0.3 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.2 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.0 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.0 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 2.2 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.2 | GO:0033363 | secretory granule organization(GO:0033363) |
0.0 | 0.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.0 | 0.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.0 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.0 | 0.2 | GO:0032402 | melanosome transport(GO:0032402) |
0.0 | 0.8 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.6 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.0 | 0.0 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.6 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.0 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.0 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.0 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.3 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.5 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.0 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.0 | 0.0 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.4 | GO:0009132 | nucleoside diphosphate metabolic process(GO:0009132) |
0.0 | 0.0 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0015879 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.1 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.3 | GO:0055076 | transition metal ion homeostasis(GO:0055076) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.8 | GO:0018108 | peptidyl-tyrosine phosphorylation(GO:0018108) |
0.0 | 28.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.0 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.0 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.0 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.2 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.0 | 0.0 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.1 | GO:1902686 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:0051785 | positive regulation of nuclear division(GO:0051785) |
0.0 | 0.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.2 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.0 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.0 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.1 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.1 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.0 | 0.0 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.0 | 0.0 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.0 | GO:0042312 | regulation of vasodilation(GO:0042312) |
0.0 | 0.0 | GO:0015744 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
0.0 | 0.0 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.2 | GO:0009408 | response to heat(GO:0009408) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 18.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
2.6 | 10.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
2.1 | 6.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.1 | 6.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.9 | 7.6 | GO:0000938 | GARP complex(GO:0000938) |
1.8 | 9.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.7 | 10.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.7 | 6.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.6 | 26.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.6 | 4.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.6 | 11.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.6 | 11.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.4 | 2.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.3 | 1.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.2 | 6.1 | GO:0005579 | membrane attack complex(GO:0005579) |
1.2 | 3.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.2 | 8.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.1 | 7.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.0 | 5.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.0 | 4.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.0 | 2.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.0 | 39.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.9 | 2.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 3.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.9 | 5.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.8 | 3.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.8 | 1.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.8 | 4.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.8 | 10.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.8 | 4.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.8 | 3.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 3.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 1.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.7 | 6.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 7.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.7 | 7.3 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.6 | 3.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 2.5 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.6 | 11.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.6 | 1.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 1.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 1.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 8.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.6 | 3.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 12.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.6 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 10.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.6 | 4.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 5.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.5 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 2.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 2.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 3.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 1.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 6.8 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.5 | 2.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 4.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 3.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.5 | 19.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 5.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.5 | 5.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 3.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.4 | 0.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.4 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 41.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 1.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 3.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 1.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 3.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 4.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 1.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 16.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 1.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 2.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 3.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 4.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 4.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 2.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.2 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 7.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 2.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 1.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.4 | 7.0 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 4.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.4 | 1.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 1.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 9.9 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 18.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 7.9 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 3.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 3.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.4 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 0.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 1.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.4 | 0.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.4 | 2.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 0.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 0.7 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 1.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 3.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 4.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 3.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 5.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 3.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 3.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 10.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 0.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 11.0 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 0.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 2.7 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 4.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 1.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 2.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 14.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 0.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 0.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 0.9 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 3.6 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 8.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 4.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 2.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 3.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 2.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 2.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 0.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 0.6 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.3 | 2.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 2.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 16.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 9.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 8.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 1.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 0.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 1.6 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 4.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 0.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 2.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 8.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 1.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 2.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 3.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 2.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 7.9 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 1.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 3.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 2.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 3.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.2 | GO:0002177 | manchette(GO:0002177) |
0.2 | 4.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 3.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 5.4 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.2 | 1.1 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 2.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 6.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 0.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 2.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 7.4 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 8.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 9.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 8.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.2 | 1.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 1.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 2.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 4.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 2.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.3 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 1.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 15.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 2.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 7.0 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 4.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 13.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 10.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 5.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 3.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 1.5 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 4.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 7.6 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 7.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 1.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 4.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.2 | GO:0031256 | leading edge membrane(GO:0031256) |
0.2 | 0.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 2.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 1.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 1.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 2.8 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 15.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 11.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.8 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.2 | 5.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 23.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.0 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.3 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 47.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 6.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 1.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 3.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 4.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 2.5 | GO:0030135 | coated vesicle(GO:0030135) |
0.1 | 4.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 29.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 6.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 4.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.1 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 5.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 12.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 6.0 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 4.3 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.1 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.1 | 4.0 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 1.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 2.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 13.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 102.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 2.0 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.8 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 4.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 7.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 6.3 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 2.3 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 3.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 15.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 4.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 3.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.8 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 11.8 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 3.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 1.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 1.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 53.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 2.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 47.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.1 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 3.6 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 13.6 | GO:0031981 | nuclear lumen(GO:0031981) |
0.1 | 1.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0044440 | endosomal part(GO:0044440) |
0.1 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.2 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 31.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.8 | GO:0031672 | A band(GO:0031672) |
0.1 | 24.4 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 2.5 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.0 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.7 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0051286 | growing cell tip(GO:0035838) cell tip(GO:0051286) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 1.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0002141 | stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 37.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.6 | 7.9 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.6 | 7.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.3 | 18.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
2.3 | 9.1 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.9 | 9.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.8 | 1.8 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.7 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.6 | 4.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.6 | 11.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.6 | 11.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.6 | 6.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.5 | 6.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.5 | 4.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.5 | 10.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.4 | 4.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.3 | 8.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.3 | 1.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
1.3 | 5.2 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
1.3 | 3.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.3 | 3.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.2 | 3.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.2 | 4.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.2 | 1.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
1.2 | 2.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.2 | 4.7 | GO:0043515 | kinetochore binding(GO:0043515) |
1.2 | 5.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.2 | 7.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.1 | 5.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.1 | 4.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.1 | 12.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.1 | 4.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.1 | 9.8 | GO:0034582 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.1 | 1.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.1 | 4.3 | GO:0038132 | neuregulin binding(GO:0038132) |
1.0 | 3.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.0 | 4.1 | GO:0042731 | PH domain binding(GO:0042731) |
1.0 | 4.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.0 | 6.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.0 | 3.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.0 | 4.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.0 | 5.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 3.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.9 | 11.2 | GO:0016208 | AMP binding(GO:0016208) |
0.9 | 3.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.9 | 7.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.9 | 10.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.9 | 5.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.8 | 2.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.8 | 3.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.8 | 2.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 2.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.8 | 3.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.8 | 1.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.8 | 2.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.8 | 2.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 8.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.8 | 2.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.8 | 5.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.8 | 2.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 1.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.8 | 7.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.8 | 4.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.8 | 1.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.8 | 3.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.8 | 2.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.8 | 7.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.8 | 4.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.7 | 2.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.7 | 8.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 3.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.7 | 2.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 12.5 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.7 | 2.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 2.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.7 | 1.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.7 | 3.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.7 | 4.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.7 | 8.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 2.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.7 | 0.7 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.7 | 2.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.7 | 6.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.7 | 13.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.7 | 1.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.7 | 4.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.7 | 11.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.7 | 5.2 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.6 | 3.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 8.4 | GO:0010181 | FMN binding(GO:0010181) |
0.6 | 2.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.6 | 4.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 0.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.6 | 1.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.6 | 3.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.6 | 8.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.6 | 3.1 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 1.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 4.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.6 | 5.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.6 | 4.3 | GO:0018639 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 3.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 4.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.6 | 3.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 7.4 | GO:0043176 | amine binding(GO:0043176) |
0.6 | 7.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.6 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.6 | 2.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.6 | 2.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 4.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 4.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.6 | 1.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.6 | 4.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 1.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 2.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 5.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 6.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 1.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 1.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 4.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 8.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.5 | 3.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.5 | 1.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.5 | 3.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 4.9 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.5 | 2.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 8.0 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 6.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 11.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.5 | 1.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.5 | 3.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 3.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 3.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 5.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 2.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.5 | 1.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 1.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 10.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 1.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 1.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.5 | 3.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 5.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 4.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 18.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.5 | 2.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.5 | 1.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.5 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 2.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 1.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 2.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 1.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 1.8 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 1.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 6.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 0.4 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.4 | 3.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 3.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 2.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 6.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 3.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 1.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 3.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 0.4 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.4 | 5.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 0.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 6.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 5.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 5.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.4 | 1.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 1.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.6 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.4 | 1.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 2.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 1.5 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 5.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 4.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 5.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 17.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.4 | 1.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 2.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 2.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 11.1 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 2.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 1.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 3.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 1.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 1.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 1.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 4.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 1.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 0.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 3.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 1.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.7 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 1.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 2.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 2.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 1.7 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 3.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 61.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 2.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 1.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 1.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 2.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 2.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 23.8 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.3 | 4.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 2.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 13.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 2.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 1.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 2.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.3 | 8.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 0.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 1.9 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 0.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 1.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 3.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 0.9 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 0.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 4.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 0.6 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.3 | 2.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 0.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 1.2 | GO:0048038 | quinone binding(GO:0048038) |
0.3 | 1.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 0.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 0.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 1.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 1.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 2.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 1.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 1.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 0.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 2.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 14.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 1.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 6.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 1.1 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 0.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 7.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 2.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.3 | 0.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 14.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 1.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 0.8 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 2.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 10.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 1.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 4.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 0.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 0.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 2.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 3.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 1.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 3.4 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 0.5 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 1.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 4.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 1.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 2.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
0.3 | 1.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.8 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 2.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 2.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 1.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 4.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 2.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 13.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 2.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 4.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 1.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 4.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 3.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 5.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.2 | 1.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 2.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 1.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 6.7 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 3.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 1.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 4.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 1.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.7 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 11.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 9.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 2.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 7.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.6 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 3.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 4.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 2.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 5.7 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 0.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 2.1 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 1.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 39.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 7.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 2.6 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 22.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 0.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 8.6 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 5.2 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 0.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 2.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 1.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 2.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 1.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 2.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 3.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.6 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 1.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 1.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.3 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 2.4 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 3.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 0.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 3.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 5.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 4.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 14.9 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 2.9 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 0.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 2.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.2 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 11.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.2 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.2 | 1.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 1.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 1.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 13.5 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 0.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 4.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 2.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 4.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 0.9 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.2 | 17.1 | GO:0005506 | iron ion binding(GO:0005506) |
0.2 | 7.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.2 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.7 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 7.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.4 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 2.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 1.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 4.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.7 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.4 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 1.1 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 2.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 1.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 3.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.1 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 15.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 1.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 1.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.8 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 20.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 1.1 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.6 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 1.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 3.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 1.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 10.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 3.4 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 2.8 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 5.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 1.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 2.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.5 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 1.7 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 3.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 2.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 7.3 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 2.0 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0051379 | epinephrine binding(GO:0051379) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 2.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.5 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 2.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 4.6 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.1 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 8.5 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 5.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 2.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 1.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.5 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 1.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.1 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.2 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.1 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.7 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.9 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 1.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 18.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 2.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.0 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 3.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.2 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 0.5 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 2.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 5.7 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.0 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.4 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 12.2 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 31.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.0 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.0 | 2.5 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.0 | 0.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.2 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.2 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 1.6 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.3 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.0 | 0.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 7.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 1.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 19.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 22.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.5 | 5.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 7.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 1.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.5 | 12.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.5 | 10.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 26.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.5 | 11.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.5 | 4.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 14.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 11.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 6.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 24.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 4.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 4.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 17.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 8.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 10.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.4 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 1.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 15.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 8.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 2.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 7.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 1.2 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 6.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 1.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 3.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 10.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 10.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 2.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 1.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 5.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 9.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 10.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 11.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 2.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 3.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 4.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 1.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 6.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 3.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 5.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 2.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 0.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 3.9 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 3.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 7.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 2.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 4.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 4.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 3.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 2.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 3.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 5.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 10.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 3.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.6 | 23.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.5 | 21.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.2 | 17.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.2 | 5.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.1 | 4.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.0 | 15.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.9 | 9.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 5.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.8 | 8.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.8 | 7.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 7.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 9.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.7 | 3.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 5.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 17.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.7 | 9.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.7 | 7.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 7.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 7.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 7.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 0.6 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.6 | 5.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.5 | 8.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 14.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.5 | 0.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.5 | 3.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 13.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 7.6 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.5 | 4.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 10.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 5.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 11.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 23.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 3.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.5 | 5.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 9.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 6.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.5 | 0.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.5 | 8.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 13.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 7.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 11.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.4 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 5.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 8.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 7.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 4.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 5.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 7.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 3.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 0.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 5.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 7.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.4 | 3.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 8.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.4 | 8.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 5.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 2.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 2.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 2.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.3 | 8.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 4.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 3.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 3.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 3.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 1.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 0.6 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.3 | 0.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 3.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 8.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.3 | 3.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 10.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 4.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 4.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 2.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 1.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 1.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 2.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 8.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 6.9 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.3 | 13.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 3.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 2.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 4.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 1.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 5.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 11.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 1.7 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 2.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 3.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 1.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 0.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 2.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 3.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 9.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 2.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 1.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 27.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 4.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 2.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 3.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 0.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 4.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 2.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 4.3 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.2 | 1.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 0.8 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 2.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 10.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 15.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 0.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 3.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 0.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 3.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 1.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 5.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 3.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 1.6 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 7.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 4.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 3.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 8.7 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 14.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.3 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 3.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 2.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 7.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 4.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 3.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 2.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.2 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 2.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.4 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 1.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 8.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 2.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.9 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 3.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 2.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |